PRTN3 and rheumatoid arthritis: A subset of LDNs, elevated in RA, may be characterized by enhanced NETosis, an aberrant release of NETs composed of self-DNA, myeloperoxidase (MPO), and proteinase 3 (PR3) that directly contributes to synovial tissue damage (Figure 2).